{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2489, 
        2499
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2580, 
        2590
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2654, 
        2668
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4382, 
        4405
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2386, 
        2413
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2294, 
        2299
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2324, 
        2328
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2522, 
        2526
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2300, 
        2320
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2329, 
        2349
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2418, 
        2428
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2510, 
        2520
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        549, 
        578
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4081, 
        4116
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2263, 
        2289
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2476, 
        2499
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2567, 
        2590
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        3315, 
        3316
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2670, 
        2683
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2688, 
        2689
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2353, 
        2361
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2644, 
        2653
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2291, 
        2292
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2321, 
        2322
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2350, 
        2351
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2415, 
        2416
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2507, 
        2508
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2598, 
        2599
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2977, 
        2994
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^18D0326107^CLIA|eMARCPlus|KY Cancer Registry|20170914000111||ORU^R01^ORU_R01|201709140001110001|P|2.5.1|KY||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-56-002220^PathSys^18D0326107^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170825000000|||||||20170828000000|&Lymph Nodes, Regional Resection, Lymph Nodes, Regional Resection, Prostate, Radical Resection|1194923474^^^^III^^MD^^CMS^D^^^NPI||||||20170904000000|||F||||||C61^Malignant neoplasm of prostate^I10|1144411331&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. Received in fixative labeled and \"right obturator lymph node\" is a 3.3 x 2.1 x 1.5 cm piece of soft, yellow-tan, lobulated adipose tissue. Serially sectioning the specimens reveals a 1.5 x 0.9 x 0.5 cm yellow-tan lymph node. The node is trisected and totally submitted in cassette 1A, 3/1. 2. Received in fixative labeled and \"left obturator lymph node\" is a 2.9 x 2.1 x 1.5 cm piece of soft, yellow-tan, lobulated adipose tissue. Serially sectioning the specimens reveals a 0.6 x 0.5 x 0.3 cm possible lymph node. The node is bisected and totally submitted in cassette 2A, 2/1. 3. Received in fixative labeled and \"prostate with seminal vesicles\" is a 36 g specimen consisting of a prostate gland (5.0 x 4.0 x 3.6 cm) with attached bilateral seminal vesicles (2.6 and 4.0 cm in length) and attached bilateral vasa deferentia (1.2 and 1.5 cm in length). The external surface of the prostate is tan- brown with focally cautery artifact and a small amount of adherent yellow lobulated adipose tissue. The right side of the specimen is marked with red ink and the left side is marked with blue ink. Serially sectioning the prostate reveals a smooth, gray- tan-yellow, focally hemorrhagic cut surface. No discrete lesions or remarkable nodules are identified. There are numerous microcysts present within the posterior prostate; however, no definite calculi are identified. Representative sections are submitted as follows: 3A, apical margin, 4/1; 3B, bladder neck margin, 4/1; 3C, right seminal vesicle and vas deferens, 2/1; 3D, left seminal vesicle and vas deferens, 2/1; 3E-3L, right prostate from apex to base, 1/1 each; 3M-3T, left prostate from apex to base, 1/1 each. (BKC)\n\n\nPath report.site of origin\n\n1. Right obturator lymph node 2. Left obturator lymph node 3. Prostate with seminal vesicles\n\n\nPath report.final diagnosis\n\n1. Lymph node, right obturator, excision:     One lymph node negative for malignancy (0/1). 2. Lymph node, left obturator, excision:     One lymph node negative for malignancy (0/1). 3. Prostate gland, radical prostatectomy:     Prostatic adenocarcinoma, Gleason score 3+4=7 involving 50% of right lobe       and less than 5% of left lobe.     Extensive extraprostatic extension identified.     Perineural invasion identified.     Seminal vesicle negative for malignancy.     Margins negative for malignancy.     Pathologic tumor stage (AJCC 7th ed): pT3a pN0.  CANCER CHECKLIST: PROSTATE GLAND: Radical Prostatectomy 3.000.001.1000043 SPECIMEN  Procedure: Radical prostatectomy TUMOR  Histologic Type: Acinar adenocarcinoma Histologic Grade  Gleason Pattern: Gleason pattern  Primary Gleason Pattern: Pattern 3  Secondary Gleason Pattern: Pattern 4  Total Gleason Score: 7  Grade Group: Grade group 2 Tumor Extent  Tumor Quantitation: Estimated percentage of prostate involved by tumor (specify %)  Estimated percentage of prostate involved by tumor (specify %): 50%  Extraprostatic Extension (EPE): Present, nonfocal  Urinary Bladder Neck Invasion: Not identified  Seminal Vesicle Invasion: Not identified Accessory Findings  Treatment Effect: No known presurgical therapy MARGINS  Margins: Uninvolved by invasive carcinoma LYMPH NODES  Number of Lymph Nodes Involved: None identified  Number of Lymph Nodes Examined: Specify number  Specify number: 2 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  Primary Tumor (pT)#: pT3a: Extraprostatic extension or microscopic invasion of bladder neck  Regional Lymph Nodes (pN): pN0: No positive regional nodes\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed. Immunohistochemical stain for PIN4, CD34 and D2-40 are performed. Dilated areas surrounding neoplastic cells is consistent with retraction artifact, supported by staining pattern of CD34 and D2-40. Multiple levels examined.\n\n\nPath report.relevant Hx\n\nHistory - Prostate cancer\n\n\n"
}